SS
BEAM icon

SBI Securities’s Beam Therapeutics BEAM Stock Holding History

SBI Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Buy
4,549
+825
+22% +$22.9K ﹤0.01% 828
2025
Q4 		$103K Sell
3,724
-285
-7% -$7.27K ﹤0.01% 834
2025
Q3 		$97.3K Buy
4,009
+3,007
+300% +$59.8K ﹤0.01% 855
2025
Q2 		$17K Buy
1,002
+523
+109% +$9.11K ﹤0.01% 1477
2025
Q1 		$9.36K Buy
479
+145
+43% +$3.8K ﹤0.01% 1634
2024
Q4 		$8.28K Buy
+334
New +$8.52K ﹤0.01% 1718

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SBI Securities's BEAM Position: Q1 2026 in Review

SBI Securities increased its Beam Therapeutics (BEAM) stake by 22% in Q1 2026, buying an estimated $22.9K and bringing the position to 4,549 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #828.

SBI Securities first reported a position in BEAM in Q4 2024 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • SBI Securities held 4,549 shares of Beam Therapeutics worth $108K as of Q1 2026.
  • SBI Securities bought 825 Beam Therapeutics shares in Q1 2026, an estimated $22.9K.
  • Beam Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #828 holding.
  • SBI Securities first reported a position in Beam Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.